Professor, Medical editor/writer

Andrei Surguchov, Ph.D.

Professor, Kansas University Medical Center,

Senior Medical Writer, Responsum Health

913-***-****, **************@*****.***; **********@****.***

OBJECTIVE:

A challenging position of Medical Editor, which requires qualities of a strong technical leader and manager with excellent strategic and customer-focused leadership. The position is based on my experience in writing, reviewing and editing of scientific and medical manuscripts, abstracts and posters.

SUMMARY OF QUALIFICATION:

Extensive scientific knowledge, expertise in multiple biomedical areas. Experience in reviewing and editing scientific and medical texts based on work as editor in several journals.

Expertise on the research of mechanisms of human diseases based on knowledge of biochemistry, molecular biology, neurology and pharmacology.

· Ability to clearly articulate scientific and clinical data in written and verbal communication,

knowledge of AMA writing style and GPPIII and ICMJE guidelines. Experience with advanced

writing features in MS Word.

· Reliable time management skills and ability to manage expectations and time pressures

associated with responding to client needs.

· As a researcher I perform literature searches and prepare summaries of literature. More than 20

review articles are published in high ranking biomedical journals (see list of publications below).

Excellent team-working and oral and written communication skills as evidenced by:

oPreparing scientific data for publication: published ~75 review and research papers.

oPreparing and giving presentations in either oral or poster formats:

30 oral and poster presentations at a variety of scientific meetings.

Writing grant proposals for federal institutions and private foundations. More than 10 of them were funded.

Analytical skills:

Troubleshooting and optimization of experimental procedures.

Analysis of complex scientific results both for laboratory experiments and published data.

Ability to clearly articulate scientific and clinical data in written and verbal

communication. Experience with advanced writing features in MS Word and other

Microsoft Office software.

Editing and reviewing manuscripts for a peer-reviewed journals. Member of editorial boards in ~12 journals, reviewer in many biomedical journals.

Team-work:

Working in a goal-oriented collaborative environment.

Leadership/managerial experience:

oInstructed and supervised junior team members.

oEstablished successful relationships with key opinion leaders, scientists and physicians.

GRANT REVIEWER:

Special Emphasis Panel/Scientific Review Group CSR/NIH, NEI, Challenge Grants (Panel 3).

Reviewer of applications in NINDS/NIH, in response to RFA-NS-17-016 (Apr 2017).

Reviewer in the Alzheimer's Association International Research Grant Program.

Reviewer in Israel Science Foundation (ISF, 2017). Parkinson’s UK; Glaucoma Foundation; The University of Kansas Alzheimer’s Disease Center; Midwest Biomedical Research Foundation (MBRF). Established successful relationships with key opinion leaders, scientists and physicians.

MEMBERSHIPS, AWARDS:

Member of R@D Committee, VA Medical Center, Kansas City.

Committee Member-Reviewer, 5th International Conference on Biotechnology, Food and Animal

Science, Barcelona - ABIFA '16

Honorable Organizing Committee Member, 2nd World Congress on Biopolymer, Manchester, UK,

August 2016.

Organizing Committee Member at Biopolymers and Bioplastics-2017, 5th International Conference

and Exhibition on Biopolymers and Bioplastics, October 19-21, 2017, San Francisco, USA.

Member of the Steering Committee of the Conference on Neurology, SCON Global Summit, Las

Vegas, USA 2019

EDITOR, REVIEWER:

Editor in Biomedical Research International, Associate Editor in Frontiers in Molecular Neuroscience,

Frontiers of Cellular Biochemistry, Cell and Developmental Biology, Molecular Biosciences,

Neurodegeneration.

Certificate of Outstanding reviewer in Tissue and Cell, Archives of Biochemistry and Biophysics, 2017,

2018. Certificate of Recognized reviewer in Tissue and Cell, Archives of Biochemistry and

Biophysics, Experimental Eye Research, Molecular and Cellular Neuroscience, Neuroscience

Letters, FASEB and other journals.

KEY RESEARCH CONTRIBUTIONS:

2001- 2016 - Research biologist and Medical writer VA Medical Center, Kansas City, MO

2009- current – Professor, Kansas University Medical Center (joint appointment)

2019- July 2020 –Senior writer in Responsum Health (part time)

2019- current - Editor in EaseEditing (part-time)

Writing experience:

Wrote and edited 20 manuscript for high ranking biomedical journals, all of them were published.

Wrote and submitted 18 grant proposals, 5 of which were funded.

Wrote and submitted 16 Abstracts and texts for oral presentations for national and International

meetings all of which were presented.

Research experience:

Discovered a role of g-synuclein as the major contributor to the molecular mechanism of neurodegenerative diseases and cancer. Collaborated with 12 scientists on projects studying molecular mechanisms of neurological disorders.

oInvestigated the role of g-synuclein as a regulator of gene expression and signaling pathways. Established its role as an initiator of the formation of protein aggregates in brain cells.

oExplored the role of caveolins in retinal diseases, including retinal degeneration and glaucoma.

oInvestigated how matrix metalloproteinases MMP-9 and MMP-2 are implicated in glaucoma and other eye diseases.

oPrepared and submitted ~ 15 articles published in high ranking scientific journals.

oPresented 20 oral and poster presentations at the Society for Neuroscience, ARVO and other meetings

oSubmitted several grant proposals, four of which were funded (two in federal institutions and two in private foundations.

oOrganized and oversaw weekly laboratory meetings for research group.

Associate Professor 1998 - 2001 Washington University, St. Louis, MO

Performed structure-function studies of synuclein’s role in health and human diseases. Studied matrix metalloproteinase 9 (MMP-9) in neurodegenerative diseases and cancer.

Wrote and published 5 research papers as a major author. Presented 5 oral and poster presentations.

Oversaw the work of a group of 4 scientists and technicians in the laboratory of retinal biology.

Submitted several grant proposals, 3 of which were funded.

Senior Investigator 1995-1998 University of Utah, UT

Identified a new retinal protein synoretin (g-synuclein) and investigated its role in health and diseases.

Published two research papers and made 3 oral/poster presentation at ARVO meetings

Assistant Professor,

1992-1995 Baylor College of Medicine, Houston, TX

Investigated genetic control of lipid metabolism and role of apolipoproteins in cardio-vascular diseases

Established a correlation between polymorphism in apolipoprotein III promoter region and predisposition to hyperlipoproteinemia

Found a role of apolipoprotein E (apo-E) in polymorphisms in coding region and the development of atherosclerosis and hyperlipoproteinemia.

Published five articles in scientific journals.

EDUCATION:

Ph.D. Biochemistry and Molecular Biology, Moscow University, Russia

M.S. Biochemistry, Moscow University, Russia

B.S. Biochemistry, Moscow University, Moscow, Russia

PROFESSIONAL ACTIVITIES:

Society for Neuroscience, 2010 - current

Association for Research of Vision and Ophthalmology (ARVO) 1999 -2012

Invited reviewer for peer review journals 2012- current

Chief Editor – Biochemistry Research International; Member of Editorial Board in Frontiers in Molecular Neuroscience, Cell Biochemistry and other 10 Scientific Journals, 2014- current

SELECTED PEER-REVIEWED PUBLICATIONS:

Chapters in the books.

1 A. Surguchov. Molecular and cellular biology of synucleins. International Review of Cell and

Molecular Biology, 270, 225-317, 2008.

2 A. Surguchov. Intracellular dynamics of synucleins: Here, there and everywhere. International

Review of Cell and Molecular Biology, 2015, 320:103-169.

3 Surguchov A. in “Protein Aggregation” (Editor: DA Stein). Folding and unfolding of synucleins,

Nova Science Publishers, 2011

4 Surguchov A.” Advances in Brain Research” (Eds: OB. Williams, GI Wilson). “Two Faced

Members of the Family: The Synucleins”, 2012.

5 Surguchov A. Academic Editor. “Synucleins: Biochemistry and role in diseases”, 2018.

IntechOpen.

6 Surguchov A. Reviewer of the book "Frontiers in Clinical Drug Research - Alzheimer Disorders”.

Bentham Science Publishers. 2018.

7 Emamzadeh FN and Surguchov A. Parkinson’s disease. In: ”Predictive imagable biomarkers for

brain disorders”. June 2019, Front. Neurol. Eds: PK. Mandal, L Ersland, doi:

10.3389/fneur.2019.00583.

8 Surguchov A. Biomarkers in Parkinson’s disease. Chapter in a book: “Towards Translating

Biomarker Research of Neurodegenerative Diseases to Clinical Practice”, Neuromethods Series by

Springer Nature. Eds. P. Peplow, B. Martinez, TA Gennarelli (accepted, 2020).

Articles in peer reviewed journals

Pronin AN, Morris AJ, Surguchov A, Benovic JL. Synucleins are a novel class of substrates for G

protein-coupled receptor kinases. J Biol Chem. 2000, 275, 265**-***** (>420 citations).

A. Surguchov, B. McMahon, E. Masliah, I. Surgucheva. Synucleins in ocular tissues. J Neurosci Res,

2001, 65, 68-77

A. Surguchov, RE. Palazzo, and I. Surgucheva. Gamma synucleins: subcellular localization in

neuronal cells and effect on signal transduction. Cell Motility and Cytoskeleton, 2001, 49, 218-228

Surgucheva I., McMahan B, F. Ahmed, Tomarev S, Wax MB, Surguchov A. 2002. Synucleins in

glaucoma. J Neurosci Res, 68: 97-106.

Surgucheva I, Sivak, JM, Fini ME, Palazzo RE and Surguchov A. Effect of g-synuclein expression on

matrix metalloproteinases. Arch Biochem Biophys. 2003, 410:167-176.

Maurage CA, Ruchoux MM, De Vos R, Surguchov A, Destee A. Retinal involvement in dementia with

Lewy bodies: A clue to hallucinations? Ann Neurol. 2003, 54 (4):542-7.

Snyder HM, Mensah K, Surgucheva I, Festoff B, Surguchov A, Wolozin B. β-Synuclein prevents

Proteasomal inhibition by α-synuclein but not g-synuclein. J Biol Chem, 2005. 4; 280:7562-9.

Surgucheva, B. Yue, BC Park, S Tomarev and A. Surguchov. Interaction of myocilin with g-synuclein

and its role in neurodegeneration in glaucoma. Cell Mol Neurobiol, 2005, 25, 6, 1009-33

Surgucheva I, Ninkina N, Buchman VL, Grasing K, A. Surguchov. Protein aggregation in retinal cells

and approaches to cell protection. Cellular Molecular Neurobiology, 2005, 25, 6, 1051-1066.

Surgucheva I, McMahon B., A. Surguchov. Dynamic intracellular localization of g-synuclein: a clue

to its functions. Cell Motility and Cytoskeleton, 2006, 63, 8, 447-458.

Surgucheva I, Surguchov A. 2008. g-Synuclein: Cell-Type Specific Promoter Activity and Binding to

Transcription Factors. J Mol Neuroscience, 2008; 35(3):267-71.

A. Surguchov. Molecular and cellular biology of synucleins. International Review of Cell and

Molecular Biology, 2008, 270, 225-317.

I Surgucheva, A Shnyra, J Goldberg, A. Weisman and A Surguchov. g-Synuclein as a marker of the

retinal ganglion cells, Molecular Vision, 2008, 14:1540-1548.

I Surgucheva, V Shestopalov and A Surguchov. Effect of g-synuclein silencing on apoptotic

pathways in retinal ganglion cells. J Biol Chem, 2008, 284 (52): 36377-85.

A. Surguchev and A. Surguchov. Conformational Diseases: Looking into the eyes. Brain Research

Bulletin, 2010, 81, 12-24

Surgucheva I, Chidambaram K, Willoughby DA, Surguchov A. MicroRNA regulates MMP-9

expression. J Ocular Biology, Diseases and Bioinformatics, 2010; 3: 41-52,

Surgucheva I, McMahon B, Surguchov A. Patterns of synuclein expression throughout lens

development. J Biophys Chem. 2010; 1: 12-18

Surguchov A. in “Protein Aggregation” (Editor: DA. Stein). Folding and unfolding of Synucleins, Nova

Science Publishers, 2011; 7, 179-192

Surgucheva I and Surguchov A. Expression of caveolins in trabecular meshwork cells and its

implication in pathogenesis of glaucoma. Molecular Vision 2011;17: 2878-2888

Surgucheva I, Sharov V; Surguchov, A. g-Synuclein: Seeding of α-Synuclein Aggregation and

Transmission Between Cells. Biochemistry, 2012; 51(23):4743-54

Surguchov A. Synucleins: are they two-edged swords? J Neurosci Res, 2013; 91 (2):161-6.

Surguchov A. Parkinson’s disease: Is there a light at the end of a tunnel? (Editorial). Advances in

Parkinson’s Disease, Nov 2013, 2, 3, 116-117.

Surgucheva I, Gunewardena S, Rao HS, Surguchov A. Cell-specific post-transcriptional regulation of

g-synuclein gene by micro-RNAs. PLOS One, Sep 2013, PONE-D-13-25172

Surguchov A. What do synucleins do in the nucleus? (Editorial). Journal of Genetics, Molecular and

Biology, 2014, 1, 1.

Surguchov A. SNCG (synuclein, gamma). Atlas Genet Cytogenet Oncol Haematol. June 2014. URL:

http://AtlasGeneticsOncology.org/Genes/SNCGID42343ch10q23.html

Surgucheva I, Newell KL, Burns J and Surguchov A. New α- and g-Synuclein

Immunopathological Lesions in Human Brain. Acta Neuropathologica Com, 2014, 2: 132.

Surgucheva I, He S, Sharma R, Rich M, Ninkina NN, Stahel P, Surguchov A. Role of synucleins in

traumatic brain injury. Mol Cell Neurosci. 2014, 63, 114–123.

Surguchev A, Surguchov A. Effect of a-synuclein on membrane permeability and synaptic

transmission: a clue to neurodegeneration? J Neurochemistry, 2015; 132 (6): 619-21

Surguchov A. Intracellular dynamics of synucleins: Here, there and everywhere. International Review

of Cell Molecular Biology, 2015; 320:103-169.

Surguchov A. Atlas of Genetics and Cytogenetics in Oncology and Hematology, 2015, 19, 210-217.

Surguchov A. Parkinson’s disease and cancer: positive and negative associations. OncToday, 2016

Surguchov A. Parkinson’s disease: early diagnosis and association with melanoma. Brain Sci. 2016,

6(2), 17; doi: 10.3390/brainsci6020017.

Surguchov A. g-Synuclein as a cancer biomarker: viewpoint and new approaches.

Oncomedicine, 2016, 1:1-3. doi:10.7150/oncm.16748.

Surguchov A. Type-2 diabetes and Parkinson’s disease: a cross-talk between main players. Journal

of Diabetes Mellitus and Metabolic Syndrome, 2016, 1, 1-7.

Roman A, M Kukharsky, A Surguchov, N Ninkina, V Skvortsova et al. g-Synuclein autoantibody in

the serum of patients with CVD and ALS. Annals Biol Sci, 2017, 472, 5.

Surguchov A, Singh V, Surgucheva I, Sharma M, Singh V. New putative epigenetic mechanism of

epilepsy. Frontiers in Neurology, 2017, 8:3. doi: 10.3389/fneur.2017.00003.

Surguchev AA and Surguchov A. Synucleins and gene expression: ramblers in a crowd or cops

regulating traffic? Front. Mol. Neurosci. July 2017, 10, 1-7 224 doi: 10.3389/fnmol.2017.00224

Surguchov A. α-Synuclein Interacts with Lipoproteins in Plasma. Frontiers in Molecular

Neuroscience, 2017, Nov 2, 2017. doi: 10.1007/s12031-017-0967-0.

Emamzadeh FN and Surguchov A. Parkinson’s disease: Biomarkers, Treatment, and Risk Factors .

Frontiers in Neuroscience, Neurodegeneration, 12, 61230, August 2018

https://doi.org/10.3389/fnins.2018.00612

Surguchov A. Academic Editor of a Book: “Synucleins: Biochemistry and role in diseases”, 2018.

IntechOpen.

Surguchov A. Protein-DNA interaction: one step closer to understanding the mechanism of

neurodegeneration. October 2018, J Neurosci Res., DOI: 10.1002/jnr.24346.

Surguchov A. Reviewer of the book chapter "Frontiers in Clinical Drug Research - Alzheimer

Disorders”. Bentham Science Publishers. 2018.

Surguchev AA, Emamzadeh FN, Surguchov AA. Molecules. 2019 Jan 15;24(2). pii: E305. doi:

10.3390/molecules24020305. PMID: 30650656

Surguchev AA, Surguchov A. Integrins-A missing link in synuclein's pathogenic mechanism.

J Neurosci Res. 2019 Jan 16. doi: 10.1002/jnr.24384. PMID: 30648275

Surguchev AA, Emamzadeh FN, Surguchov A. Cell responses to extracellular a-synuclein.

Molecules 2019, 24(2), 305; https://doi.org/10.3390/molecules24020305.

Mojbafan M, Surguchov A, Amini M, Zeinali S. Genetic characteristic of patients with limb girdle

muscular dystrophy: an evidence of a founder effect. Biomed Res International, 2019, submitted.

Surguchov A, Emamzadeh FN, Surguchov AA. Amyloidosis and longevity: a lesson from plants.

Biology, 2019, 8(2), 43; https://doi.org/10.3390/biology8020043

Emamzadeh FN and Surguchov A. Parkinson’s disease. In: ”Predictive imagable biomarkers for

brain disorders”. June 2019, Front. Neurol. Eds: PK. Mandal, and L Ersland.

Surguchov A. “Little pigeons can carry great messages” in a book: “Synucleins: Biochemistry and

role in diseases”, IntechOpen, 2019.

Emamzadeh FN and Surguchov A. Parkinson’s disease. In: ”Predictive imagable biomarkers for

brain disorders”. June 2019, Front. Neurol. Eds: PK. Mandal, L Ersland, doi:

10.3389/fneur.2019.00583.

Surguchov A. Caveolin: a new link between diabetes and Alzheimer’s disease. Cell Mol

Neurobiology, 2020 Jan 23. doi: 10.1007/s10571-020-00796-4

Surguchev AA, Surguchov A. A member of the ABC transporter family in healthy and ailing brain.

(Editorial) Brain Sciences, February 2020, 10, 121; doi:10.3390/brainsci10020121

Surguchov A. Analysis of protein conformational strains – a key for new diagnostic methods.

International Journal of Molecular Science, 2020, 21, 2801; doi:10.3390/ijms21082801

Surguchov A. Biomarkers in Parkinson’s disease. Chapter in a book: “Towards Translating

Biomarker Research of Neurodegenerative Diseases to Clinical Practice”, Neuromethods Series by

Springer Nature. Eds. P. Peplow, B. Martinez, TA Gennarelli, 2020 (accepted).

Surguchov A. When pandemic meets epidemic: COVID-19 and neurodegenerative diseases

(Editorial) Biochemistry Research International, 2020 (accepted).

Website: http://genetics1972.org/Andrei/

Linkedin: https://www.linkedin.com/pub/andre-surguchov/13/317/a52

Contact this candidate